APA (7th ed.) Citation

Teplyakov, A. T., Shilov, S. N., Popova, A. A., Berezikova, E. N., Neupokoeva, M. N., Grakova, E. V., & Kopeva, K. V. The prognostic value of the NT-proBNP biomarkers and Fas ligand in assessing the risk of cardiotoxicity of anthracycline chemotherapy. «SILICEA-POLIGRAF» LLC.

Chicago Style (17th ed.) Citation

Teplyakov, A. T., S. N. Shilov, A. A. Popova, E. N. Berezikova, M. N. Neupokoeva, E. V. Grakova, and K. V. Kopeva. The Prognostic Value of the NT-proBNP Biomarkers and Fas Ligand in Assessing the Risk of Cardiotoxicity of Anthracycline Chemotherapy. «SILICEA-POLIGRAF» LLC.

MLA (9th ed.) Citation

Teplyakov, A. T., et al. The Prognostic Value of the NT-proBNP Biomarkers and Fas Ligand in Assessing the Risk of Cardiotoxicity of Anthracycline Chemotherapy. «SILICEA-POLIGRAF» LLC.